Editorial Commentary: Should Heterogeneous Response Be Considered as New Category for Assessing Treatment Response in Patients with Breast Cancer?
AuthID
P-017-RHG
P-017-RHG
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service